Tolerance Induction Using Autologous Regulatory T Cell Infusion and Zortress (Everolimus) in Renal Transplant Recipients: a Pilot Study
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Sep 2018
At a glance
- Drugs Everolimus (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 24 Aug 2018 Planned initiation date changed from 1 Apr 2018 to 1 Sep 2018.
- 22 Jan 2018 Planned initiation date changed from 1 Dec 2017 to 1 Apr 2018.
- 19 Sep 2017 New trial record